EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dysmorphic neurons express markers of inhibitory glycinergic signaling in focal cortical dysplasia IIb

Ameesha Paliwal iD, Kevin Faust iD, Okty Abbasi Borhani iD, Mugeng Liu iD, Lauren Omoto iD, Evelyn Rose Kamski-Hennekam iD, Parsa Babaei Zadeh iD, Rifat Shahriar Sajid iD, Phedias Diamandis iD

Brain Pathology · 2026

DOI: 10.1111/bpa.70043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Pathology, 2026. Verfasst von Ameesha Paliwal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Neurons, Malformations of Cortical Development, Group I, Glycine, Malformations of Cortical Development. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Focal cortical dysplasia (FCD) is a neurodevelopmental malformation that often manifests as medically refractory epilepsy. A key histological hallmark of FCD type II is the presence of cytomegalic dysmorphic neurons (CDNs), which are considered to be major contributors to cortical network hyperexcitability. However, the relatively low frequency of CDNs within resected lesions has challenged their unbiased molecular characterization. Here, we leverage deep learning approaches to objectively map key anatomical compartments of FCD IIb and guide regional spatial transcriptomic profiling. Using this approach, we generate an anatomical transcriptional catalog of type IIb FCD, and uncover non‐canonical markers of signaling and neurotransmitter pathways in CDNs that may serve as new therapeutic targets for this debilitating disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuronsMalformations of Cortical Development, Group IGlycineMalformations of Cortical DevelopmentHumansSignal TransductionMaleFemaleTranscriptomeFocal Cortical DysplasiaEpilepsy

Stichwörter der Autor:innen

computational pathologydeep learningdysmorphic neuronsepilepsyfocal cortical dysplasiaspatial transcriptomics

Substanzen

Glycine

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Laboratory Medicine Program, Department of Pathology, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Ameesha Paliwal, Kevin Faust, Okty Abbasi Borhani, Mugeng Liu, Lauren Omoto, Evelyn Rose Kamski-Hennekam, Parsa Babaei Zadeh, Rifat Shahriar Sajid, Phedias Diamandis

Förderung

  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Paliwal, A., Faust, K., Borhani, O. A., Liu, M., Omoto, L., Kamski-Hennekam, E. R., Zadeh, P. B., Sajid, R. S., & Diamandis, P. (2026). Dysmorphic neurons express markers of inhibitory glycinergic signaling in focal cortical dysplasia IIb. Brain Pathology. https://doi.org/10.1111/bpa.70043

Vancouver

Paliwal A, Faust K, Borhani OA, Liu M, Omoto L, Kamski-Hennekam ER, et al. Dysmorphic neurons express markers of inhibitory glycinergic signaling in focal cortical dysplasia IIb. Brain Pathology. 2026. doi:10.1111/bpa.70043

BibTeX
@article{Paliwal2026,
  author = {Paliwal, Ameesha and Faust, Kevin and Borhani, Okty Abbasi and Liu, Mugeng and Omoto, Lauren and Kamski-Hennekam, Evelyn Rose and Zadeh, Parsa Babaei and Sajid, Rifat Shahriar and Diamandis, Phedias},
  title = {Dysmorphic neurons express markers of inhibitory glycinergic signaling in focal cortical dysplasia IIb},
  journal = {Brain Pathology},
  year = {2026},
  doi = {10.1111/bpa.70043}
}
Kostenlos starten →